Effect of liposome-encapsulated clodronate pretreatment on synthetic vector-mediated gene expression in mice.
One of the main limitations for the use of synthetic vectors in gene therapy is their relatively low in vivo efficiency when compared with viral vectors. Here, we describe a pretreatment protocol with liposome-encapsulated clodronate in mice by which gene expression levels of a luciferase reporter gene could be increased up to nine-fold in the lung, after intravenous (i.v.) injection of glycerolipoplexes. Optimal results were obtained if mice were pretreated with liposome-encapsulated clodronate 1 day before injection of lipoplexes. The enhancement effect could be observed for lipoplexes prepared with different multivalent cationic glycerolipids. Most remarkably, polyplexes behaved in the opposite way. Liposome-encapsulated clodronate pretreatment strongly reduced reporter gene expression after i.v. injection of polyethylenimine-polyplexes (ExGen500).
Schughart
K
K
Department of Molecular and Cellular Biology, TRANSGENE SA, Strasbourg, France.
Bischoff
R
R
Hadji
D A
DA
Boussif
O
O
Perraud
F
F
Accart
N
N
Rasmussen
U B
UB
Pavirani
A
A
van Rooijen
N
N
Kolbe
H V
HV
D000818:Animals; D004002:Clodronic Acid / Q000008:administration & dosage*; D015870:Gene Expression; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D005990:Glycerol; D007275:Injections, Intravenous; D008081:Liposomes; D008156:Luciferases / Q000235:genetics; D008168:Lung / Q000378:metabolism*; D051379:Mice; D011094:Polyethyleneimine
D008081:Liposomes; D004002:Clodronic Acid; D011094:Polyethyleneimine; D008156:Luciferases; D005990:Glycerol